BRIEF-Merck & Co Advances Mk-8527 Pre-Exposure Prophylaxis (Prep) Clinical Trials Globally

Reuters
14 Jul
BRIEF-Merck & Co Advances Mk-8527 Pre-Exposure Prophylaxis (Prep) Clinical Trials Globally

July 14 (Reuters) - Merck & Co Inc MRK.N:

  • MERCK TO INITIATE PHASE 3 TRIALS FOR INVESTIGATIONAL ONCE-MONTHLY HIV PREVENTION PILL

  • MERCK & CO INC: ADVANCES MK-8527 PRE-EXPOSURE PROPHYLAXIS (PREP) CLINICAL TRIALS GLOBALLY

Source text: ID:nBwbY8Sp9a

Further company coverage: MRK.N

((Reuters.Briefs@thomsonreuters.com;;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10